CSF2 and hepatocellular carcinoma: Considering that our group showed that MSCs have curative properties in fibrotic livers [58] it could be interesting to design an approach that combines MSCs that have the advantage of expressing GM-CSF through IVT mRNA and TACE, directing this strategy to those patients with HCC and underlying fibrosis.